... Web Images Videos Maps News Shopping Gmail more » Why is News different? | Settings | Sign in Advanced news search Undo Results 1 10 of about 4, 404 for GlaxoSmithKline. (0.21 seconds) News Top Stories More sections ? World News near you U.S. Business Sci / Tech Entertainment Sports Health Spotlight All news Images Blogs Any recent news Past hour Past day Past week Past month Sorted by relevance Sorted by date Sponsored Links Glaxo Financial News www.cantos.com / GlaxoSmithKline Interviews and analysis Register and watch for free Sponsored Links Free Glaxo Prescriptions Prescription Assistance Program Annual income under $42k to qualify www.myrxadvocate.com Reuters UK GlaxoSmithKline Recently Made` Very Casual ' Overture to Genzyme, WSJ Says Bloomberg-Vivek Shankar-11 hours ago GlaxoSmithKline Plc recently made a â € œvery casualâ € overture to Genzyme Corp, asking the biotechnology company to keep it in. Is Biogen Back in Play? Wall Street Journal (blog) AM Vitals: Could Genzyme Attract Other Suitors? Wall Street Journal (blog) European shares dip, drugmakers offset rising banks Reuters TheStreet.com all 77 news articles ...

... drug until Dec. 30 7: 23 PM 9 / 20 / 2005 Reuters-USA (CEPH.O: Quote, Profile, Research) and Alkermes Inc. (ALKS.O: Quote, Profile, Research) on Tuesday said the US Food and Drug Administration has extended to. Glaxo Settles Drug Pricing Charges for $150M 3: 46 PM 9 / 20 / 2005 FOX News-USA The Justice Department" will not tolerate fraudulent pricing practices designed to reap profits for drug companies and doctors at the expense of health care. GlaxoSmithKline pays 150 mln usd to settle US drug pricing case 3: 45 PM 9 / 20 / 2005 Forbes-USA these types of fraud schemes vigorously to make clear that we will not tolerate fraudulent pricing practices designed to reap profits for drug companies and. US spurns injectable Pfizer drug similar to Bextra 12: 01 PM 9 / 20 / 2005 Reuters.uk-UK CHICAGO (Reuters)-US regulators have rejected Pfizer Inc 's application to market an injectable drug very similar to its withdrawn Bextra arthritis pill, the. Glaxo settles drug ...

... Jump to navigation Jump to footer Home About us Our mission and strategy Our products Collaborations Responsibility Our work with communities Research & development Investors Media centre Careers Contact us Advanced search GSK in focus Reports and publications GSK worldwide Site map GlaxoSmithKline Do more, feel better, live longer Avandia Resource Centre Annual Report 2009 Q2 2010 results announcement GSK worldwide Please select Albania Algeria Argentina Armenia Australia Austria Azerbaijan Bangladesh Belarus Belgium Belgium-GSK Biologicals Bosnia Herzegovina Brazil Bulgaria Cambodia Canada Chile China Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Egypt El Salvador Estonia Finland France Germany Georgia Greece Guatemala Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Jamaica Japan Kazakhstan Kenya Korea Latvia Lithuania Macedonia Malaysia Malta Mexico Moldova Morocco Myanmar Netherlands New Zealand Nicaragua Nigeria Norway Pakistan Panama Peru Philippines Poland Portugal Romania Russia Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa Spain Sri Lanka Sweden Switzerland Taiwan Thailand Trinidad Turkey Ukraine United Kingdom United States Uruguay Uzbekistan Venezuela Vietnam GSK worldwide For US residents US corporate website US media and news More Than Medicine blog Avandia regulatory update 21 July 2010: GlaxoSmithKline statement in response ...

... it is now in phase two of. Drug linked to liver problems MarketWatch-USA BOSTON (MarketWatch)-Biogen Idec Inc 's multiple sclerosis drug Avonex has been linked to severe liver damage in certain patients, the Food and Drug. Fujisawa Gains US Approval to Sell Micafungin (Update1) Bloomberg-USA March 17 (Bloomberg)-Fujisawa Pharmaceutical Co, which will be bought by rival Yamanouchi Pharmaceutical Co. next month, said. Tanabe Falls After US Suspends Multiple Sclerosis Drug Bloomberg-USA. in early trading after GlaxoSmithKline Plc, Europe's biggest drugmaker, said US regulators suspended clinical trials of its experimental multiple sclerosis drug. GlaxoSmithKline: FDA halts trials of drug BusinessWeek-USA 16 5: 14 PM ET European drugmaker GlaxoSmithKline PLC said Wednesday it had suspended clinical trials of an experimental drug to treat multiple sclerosis and. FDA Approves Amylin Diabetes Drug Symlin Reuters-USA. Inc. won US approval to market its diabetes drug Symlin, a US Food and Drug Administration spokeswoman said on Wednesday. Amylin. FindingHealthOnline | Drug Thesaurus | Brand Names | Generic ...

... Search | Generic Drug Companies | Company Name | API | Pharma Stocks | News-Archive Today's News | Note: News feeds may no longer be available for the articles on this page. FDA approves Exelixis thyroid cancer drug trial 8: 53 AM 6 / 16 / 2008 Bizjournals.com-Charlotte, NC, USA Exelixis Inc plans to begin the late-stage trial of XL184 this summer enrolling 315 patients.. Glaxo, SkyePharma gain on Requip XL drug approval 8: 23 AM 6 / 16 / 2008 Reuters-USA Shares in GlaxoSmithKline and SkyePharma advanced following news Glaxo had finally won US FDA approval for its drug Requip XL as a treatment for Parkinson's disease.. Teva says Azilect slows progression of Parkinson's 7: 57 AM 6 / 16 / 2008 CNNMoney.com-USA Teva Pharmaceutical Industries said trial data from its Parkinson's disease drug Azilect showed it slows the progression of the disease.. European firms beat US on drug access for poor 7: 03 AM 6 / 16 / 2008 Reuters-USA European drugmakers are better than their US counterparts in ensuring medicines reach people ...

... disease.. Novartis Copy of Bayer's Betaseron MS Drug Wins US Approval 5: 10 AM 8 / 17 / 2009 Bloomberg Novartis won US FDA approval to sell its Extavia multiple sclerosis treatment which is a form of interferon beta-1b similar to Bayer AG ’ s Betaseron.. Drug-resistant swine flu cases discovered in patients in Seattle 9: 49 AM 8 / 15 / 2009 Boston Herald The country ’ s first cases of drug-resistant swine flu were discovered in two leukemia patients who had weakened immune systems from chemotherapy and stem-cell transplants.. GlaxoSmithKline starts clinical trials on H1N1 swine flu vaccine 11: 49 AM 8 / 14 / 2009 Bizjournals.com GlaxoSmithKline intends to test the vaccine on over 9, 000 people in 16 separate clinical trials across Europe, the US, and Canada.. Analysts reaffirm high hopes for Amgen bone drug 9: 49 AM 8 / 14 / 2009 Forbes A US FDA advisory panel voted unanimously in favor of Amgen's denosumab as a treatment for postmenopausal osteoporosis.. Roche transplant drug gets anemia warning 7: 33 AM 8 / 14 / 2009 Reuters Roche ...

... Service not currently available or no longer active We are sorry, the page you were trying to reach is currently not available or no longer active. If you are looking for information about GlaxoSmithKline or its products please go to gsk.com. Copyright 2008, GlaxoSmithKline Group of Companies All Rights Reserved. ...

... USA climbed 4 cents to $21.15 after seeing its profits triple in the third quarter from strong sales of a number of products, including the allergy drug Nasonex.. Vytorin Lifts Schering-Plough 12: 07 PM 10 / 24 / 2005 MSNBC-USA In the case of pharmaceutical company Schering-Plough (NYSE: SGP ), management has now announced the official beginning of its turnaround phase.. Diet drug may go over the counter 9: 34 AM 10 / 24 / 2005 Newsday-Long Island, NY, USA The pharmaceutical company GlaxoSmithKline has asked the Food and Drug Administration for permission to sell a low-dose version of its diet drug Xenical over. | Today's News FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry Keywords from the articles above: abbott laboratories, act, adhd, allergy, attention deficit, businessweek, counterfeit, cylert, diet drug, drug makers, federal reserve chairman, flu drug, generic drug, generic drug pact, generic version, glaxosmithkline, h5n1, liver, low-dose, marketing applications, mn pharmaceuticals ...

... : Quote, Profile, Research) on Friday said it agreed to sell common stock and. Bristol-Myers Squibb diabetes drug Actos lowers heart risk-study 6: 34 AM 10 / 7 / 2005 Forbes-USA PARIS (AFX)-Bristol-Myers Squibb's Actos, a drug widely prescribed for Type 2 diabetes, also appears to lower the risk of dangerous cardiovascular problems. Glaxo Accused by Public Citizen of Misleading FDA on Drug Data 6: 14 AM 10 / 7 / 2005 Bloomberg-USA Oct. 7 (Bloomberg)-GlaxoSmithKline Plc presented misleading data on its Serevent asthma drug to the US Food and Drug Administration two years ago when the. Glaxo denies manipulating asthma drug data 8: 17 PM 10 / 6 / 2005 Reuters-USA group Public Citizen has accused GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) of manipulating clinical trial data on its asthma drug Serevent, a. Repligen drug to be tested independently 7: 11 PM 10 / 6 / 2005 BusinessWeek-USA OCT. 6 5: 56 PM ET Repligen Corp. said Thursday ...

... , rose after the company said it may sell the pharmaceuticals business because of drug-development delays.. UPDATE 1-US: Serious skin problems seen with Biogen drug 7: 31 AM 10 / 30 / 2005 Reuters-USA and sometimes fatal skin reactions have been reported in patients treated with Biogen Idec's (BIIB.O: Quote, Profile, Research) lymphoma drug Zevalin, the US. FDA approves chemotherapy drug Arranon 7: 30 AM 10 / 29 / 2005 Reuters.uk-UK WASHINGTON (Reuters)-The US Food and Drug Administration approved GlaxoSmithKline Plc's chemotherapy drug Arranon for patients with certain types of leukemia. Shire reports further positive results from Hunter Syndrome drug. 2: 44 PM 10 / 28 / 2005 Forbes-USA LONDON (AFX)-Shire Pharmaceuticals Group PLC said further results from trials of its drug to treat Hunter Syndrome, I2S, demonstrated statistically. | Today's News FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry Keywords from the articles above: altana, arranon, astrazeneca, astrazeneca's, biogen, biogen idec's, canadian ...